awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37697320-11350281-9EAA-4C91-806E-327088EF3160
Q37697320-11350281-9EAA-4C91-806E-327088EF3160
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37697320-11350281-9EAA-4C91-806E-327088EF3160
PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma.
P2860
Q37697320-11350281-9EAA-4C91-806E-327088EF3160
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37697320-11350281-9EAA-4C91-806E-327088EF3160
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a0779848fd06ddf5bb52e1807ef5a09d5e725f8
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).